Bml Capital Management, LLC Pardes Biosciences, Inc. Transaction History

Bml Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$1.4 - $1.95 $272,921 - $380,140	-194,944 Reduced 4.89%	3,791,633 $6.86 Billion
Q1 2023 Apr 14, 2023	SELL	$1.21 - $2.22 $1.07 Million - $1.96 Million	-881,407 Reduced 18.11%	3,986,577 $5.26 Billion
Q4 2022 Feb 13, 2023	BUY	$0.85 - $1.69 $4.14 Million - $8.23 Million	4,867,984 New	4,867,984 $8.23 Billion

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bml Capital Management, LLC with notifications on news.